NeuroEquilibrium, a chain of dzziness Vertigo, on Monday announced the appointment of seasoned industry veteran Samit Verma as the Chief Executive Officer. With an illustrious career of over 24 years in FMCG and healthcare, Samit brings a wealth of experience to his new role.
“Prior to joining NeuroEquilibrium, Samit held the position of Managing Director at Amplifon India, a subsidiary of Amplifon S.p.A, a renowned Italian multinational corporation and a global frontrunner in the hearing care industry across 29 countries. During his remarkable 12-year journey at Amplifon, Samit played a pivotal role in establishing the business from the ground up, growing it to encompass more than 250 point-of-sales,” the company said in a statement.
“NeuroEquilibrium is going through a fascinating phase of growth both in the domestic market and expanding our global presence, given the vast traction and demand and support from our marquee investors Kotak Ventures, Unicorn India Ventures, and RVCF ventures. We and our investors are delighted to welcome Samit Verma to the NeuroEquilibrium family,” NeuroEquilibrium Founder Rajneesh Bhandari said.
Samit Verma’s strategic vision and extensive industry expertise make him an invaluable addition to NeuroEquilibrium as the company continues its mission to excel in the field of healthcare and expand across the globe.
“I’m thrilled to take on the role of CEO at NeuroEquilibrium, a cutting-edge medical technology startup. It’s exciting to lead the world’s largest network of clinics focused on Dizziness, Vertigo, and Balance disorders. I look forward to using my experience to contribute to NeuroEquilibrium’s growth and commitment to providing excellent clinical care.” – Samit Verma, CEO, NeuroEquilibrium.
